Stents, Drug Eluting Stents, and CABG- Financial and Clinical Impact.

CompletedOBSERVATIONAL

Enrollment

700

Participants

Timeline

Start Date

November 30, 2006

Study Completion Date

May 31, 2007

Conditions

Coronary ArteriosclerosisAngina UnstableMyocardial Infarction

All Listed Sponsors

collaborator

Hebrew University of Jerusalem

OTHER

lead

Shaare Zedek Medical Center

OTHER

NCT00394680 - Stents, Drug Eluting Stents, and CABG- Financial and Clinical Impact. | Biotech Hunter | Biotech Hunter